Axsome Therapeutics, Inc. financial data

Symbol
AXSM on Nasdaq
Industry
Pharmaceutical Preparations
Location
One World Trade Center, 22 Nd Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 18, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 249 % -36.4%
Quick Ratio 8.03 % -11%
Debt-to-equity 460 % +193%
Return On Equity -290 % -158%
Return On Assets -51.7 % -18.2%
Operating Margin -72.7 % +15.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48.8M shares +2.94%
Common Stock, Shares, Outstanding 48.7M shares +2.78%
Entity Public Float 3.2B USD +14.3%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 47.9M shares +5.48%
Weighted Average Number of Shares Outstanding, Diluted 47.9M shares +5.48%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 386M USD +42.5%
Research and Development Expense 187M USD +91%
Costs and Expenses 666M USD +32.6%
Operating Income (Loss) -281M USD -21%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -287M USD -20.5%
Income Tax Expense (Benefit) 85K USD -91.1%
Net Income (Loss) Attributable to Parent -287M USD -20.1%
Earnings Per Share, Basic -5.99 USD/shares -13.7%
Earnings Per Share, Diluted -5.99 USD/shares -13.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 315M USD -18.3%
Accounts Receivable, after Allowance for Credit Loss, Current 142M USD +49.8%
Inventory, Net 15.7M USD +3.94%
Assets, Current 485M USD -3.81%
Property, Plant and Equipment, Net 584K USD -31%
Operating Lease, Right-of-Use Asset 5.38M USD -20.5%
Intangible Assets, Net (Excluding Goodwill) 46.9M USD -12%
Goodwill 12M USD 0%
Assets 568M USD -3.36%
Accounts Payable, Current 72M USD +77%
Employee-related Liabilities, Current 28.2M USD +38%
Liabilities, Current 230M USD +65.7%
Operating Lease, Liability, Noncurrent 6.05M USD -14.1%
Liabilities 511M USD +28.8%
Retained Earnings (Accumulated Deficit) -1.12B USD -34.4%
Stockholders' Equity Attributable to Parent 57M USD -70.1%
Liabilities and Equity 568M USD -3.36%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -53.5M USD -819%
Net Cash Provided by (Used in) Financing Activities -1.19M USD -102%
Net Cash Provided by (Used in) Investing Activities -98K USD -38%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 48.7M shares +2.78%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -54.8M USD -220%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 315M USD -18.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.9M USD +52.5%
Deferred Tax Assets, Valuation Allowance 282M USD +26.3%
Deferred Tax Assets, Gross 285M USD +26.4%
Operating Lease, Liability 7.88M USD -5.07%
Depreciation 132K USD +46.7%
Payments to Acquire Property, Plant, and Equipment 98K USD +38%
Lessee, Operating Lease, Liability, to be Paid 10M USD -12.3%
Operating Lease, Liability, Current 1.84M USD +44.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.52M USD +30.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.79M USD +44.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.15M USD -31.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.52M USD 0%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.2M USD +27.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 6.39M USD +0.27%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 85.2M USD +36.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%